As vaccine rollouts accelerate, we expect GDP growth to hit 5.7% in 2021, the fastest expansion rate since 1973; this is somewhat flattered by the low starting point stemming from the steep decline of 2020.
The policy backdrop remains supportive in both fiscal and monetary terms, but change is likely to slowly begin over the course of the year as countries transition from COVID stimulus measures.
Emerging Markets Outlook
Although set for GDP growth in excess of 6% in 2021, the EM outlook is somewhat muted relative to its own history — reflecting the challenges related to COVID-19 and vaccine deployment.
The robustness of global manufacturing provides a positive tailwind for EM, even if the benefit is not uniform across countries. This will help offset the need of some countries to begin withdrawing monetary and fiscal policy support.
Global Capital Markets
Signs of froth exist in some parts of the economy and financial markets, but in our view they are not widespread enough to derail the powerful economic growth associated with economies reopening with ample policy support.
The most likely path for interest rates continues to be to the upside; however, reflexive investor and central bank behavior is likely to limit the pace of future moves.
You should obtain and read a Key Investor Information Document and Prospectus relating to the SSGA Cash funds prior to investing. Further information, including the annual and semi-annual reports and the Key Investor Information Document and Prospectus describing the characteristics, charges, expenses and risks involved in your investments are available for residents of countries where SSGA cash funds are authorized for sale, at www.ssga.com/cash and from your local SSGA office or by calling +44 (0)20 3395 2333.
Investing involves risk including the risk of loss of principal. It is possible to lose money by investing in the funds.
Before investing, carefully consider a fund's investment objectives, risks, charges and expenses. Click the link to obtain a prospectus which contains this and other information, or by calling +44 (0)20 3395 2333, please read it carefully before investing.